CEO presentation at AGM 2020
Comments to the 2019 closing and 2020 update by CEO Axel Sjöblad.
This author has not written his bio yet.
But we are proud to say that Tina Dackemark Lawesson contributed 82 entries already.
Comments to the 2019 closing and 2020 update by CEO Axel Sjöblad.
The 2019 Annual Report in English is available. If you want to download it click here. To order a printed version, click here.
SenzaGen has received questions from customers and partners about how COVID-19 has affected our daily operations. We continue to monitor the development of the COVID-19 epidemic closely and recognize that […]
Join SenzaGen’s web-based conference on “Difficult-to-test” substances and regulatory testing in place of our exhibitor hosted session at SOT 2020 Take this chance and participate in our web-based conference on […]
SenzaGen has received questions from customers and partners about how COVID-19 has affected our daily operations. We continue to monitor the development of the COVID-19 epidemic closely and recognize that […]
Andy Forreryd1, Joshua Schmidt1, Robin Gradin1, Florence Burleson, Helge Gehrke3, Henrik Johansson1. 1SenzaGen AB, Lund, Sweden. 2Burleson Research Technologies, Morrisville, NC, USA. 3Eurofins BioPharma Product Testing Munich GmbH, Planegg, Germany. […]
Join SenzaGen’s free web-based SOT 2020 poster presentation session Don’t miss the opportunity to participate in our web-based conference on the latest news about the GARD™ assays for skin and […]
Did you miss our popular webinar ‘GARD technology: Genomics and Machine Learning’ last year? Here is a new opportunity to participate in a live webinar presented by GARD experts at […]
Journal of Proteomics Available online 30 January 2020, 03647. https://doi.org/10.1016/j.jprot.2020.103647 Tim Lindberg, Renato Ivan de Ávila, Kathrin S. Zeller, Fredrik Levander, Dennis Eriksson, Aakash Chawaded, Malin Lindstedt Highlights Pure glyphosate […]
Contact
Privacy Policy (En)
Privacy Policy (Sv)
General Terms and Conditions
© SenzaGen 2026
